Assessment of Ondansetron-Associated Hypokalemia in Pediatric Oncology Patients

Objectives. Ondansetron is a 5-hydroxytryptamine (5-HT(3), serotonin) receptor antagonist used as antiemetic prophylaxis preceding chemotherapy administration. Hypokalemia is a rare complication of ondansetron, which may be underreported due to confounding emesis and chemotherapy-induced tubulopathy...

Descripción completa

Detalles Bibliográficos
Autores principales: Fiedrich, Elsa, Sabhaney, Vikram, Lui, Justin, Pinsk, Maury
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scholarly Research Network 2012
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459247/
https://www.ncbi.nlm.nih.gov/pubmed/23050164
http://dx.doi.org/10.5402/2012/798239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459247/
https://www.ncbi.nlm.nih.gov/pubmed/23050164
http://dx.doi.org/10.5402/2012/798239

Ejemplares similares